Cancer immunotherapy has transformed the treatment landscape by helping the immune system recognize and attack tumors. At the heart of this approach are immune checkpoint inhibitors (ICIs), which ...

In addition, all patients with UTUC should be screened for hereditary Lynch syndrome to guide the consideration of immunotherapy (if tumors show microsatellite instability) and to allow for cascade ...

Addressing a longstanding controversy in cancer prevention, a large randomized trial showed that low-dose aspirin reduced the risk of colorectal cancer (CRC) in patients with Lynch syndrome just ...

Often corticosteroid therapy continues beyond 14-21 days to control symptoms of brain tumors, and gradual reductions in dosing must occur.

As we know, immunotherapy has truly transformed outcomes for patients with non-small cell lung cancer and melanoma, not only in systemic disease but also in brain metastases. However, what we don't ...

The legal action follows a 2024 French study that found that the use of medroxyprogesterone renders a woman five times more likely to develop a meningioma brain tumor.

Meningiomas are slow-growing tumors that are usually benign but can cause severe injury or death if they become large enough to compress the brain or spinal cord.

Lynch syndrome is a hereditary condition that sharply raises the risk of several types of cancer. Caused by inherited mutations in DNA mismatch repair genes, it affects about one in 300 people.

WebMD explains what non-muscle invasive cancer is, its symptoms, causes, diagnosis, and treatment options.

Paradromics, a brain-computer-interface startup, inserted its brain implant in a person—briefly—in an early test of its technology.

Both patients with inherited dMMR mutations, like in Lynch syndrome, and sporadic dMMR mutations were enrolled in ATOMIC. When researchers examined the outcomes of patients based on central ...